Anti-Leukemic Property of Sulphoraphane In Precursor B Cell Acute Lymphoblastic Leukemia

被引:0
|
作者
Suppipat, Koramit [1 ,2 ]
Zhu, Xiao [3 ]
Park, Chun Shik [3 ]
Lacorazza, H. Daniel
机构
[1] Texas Childrens Hosp, Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA
[2] Texas Childrens Hosp, Baylor Coll Med, Hematol Serv, Houston, TX 77030 USA
[3] Texas Childrens Hosp Pathol, Baylor Coll Med, Houston, TX USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1620 / 1621
页数:2
相关论文
共 50 条
  • [11] ANTI-LEUKEMIC, AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
    NETZEL, B
    HAAS, RJ
    RODT, H
    KOLB, HJ
    THIERFELDER, S
    BETKE, K
    EUROPEAN JOURNAL OF PEDIATRICS, 1980, 133 (02) : 185 - 185
  • [12] Expression of midkine(MDK) and sensitivity to anti-leukemic drugs in pediatric acute lymphoblastic leukemia (ALL)
    Zeng, Weihua
    Chen, I-Ming
    Tibbitts, Justin
    Kang, Huining
    Ar, Kerem
    BLOOD, 2007, 110 (11) : 429A - 429A
  • [13] URINARY SYSTEM FUNCTIONS IN CHILDREN WITH INTENSIVE ANTI-LEUKEMIC THERAPY OF ACUTE LYMPHOBLASTIC-LEUKEMIA
    MISIKOVA, Z
    LEHOTSKA, V
    NEOPLASMA, 1980, 27 (04) : 489 - 492
  • [14] Evidence of CD19-leukemic cells in B-cell precursor acute lymphoblastic leukemia
    He, H.
    Manta, L.
    Saeed, B.
    Barth-Miesala, K.
    Eckstein, V
    Trumpp, A.
    Brueggemann, M.
    Jauch, A.
    Ho, A. D.
    Lutz, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 52 - 52
  • [15] Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell lines
    Takahashi, Kazuya
    Inukai, Takeshi
    Imamura, Toshihiko
    Yano, Mio
    Tomoyasu, Chihiro
    Lucas, David M.
    Nemoto, Atsushi
    Sato, Hiroki
    Huang, Meixian
    Abe, Masako
    Kagami, Keiko
    Shinohara, Tamao
    Watanabe, Atsushi
    Somazu, Shinpei
    Oshiro, Hiroko
    Akahane, Koshi
    Goi, Kumiko
    Kikuchi, Jiro
    Furukawa, Yusuke
    Goto, Hiroaki
    Minegishi, Masayoshi
    Iwamoto, Shotaro
    Sugita, Kanji
    PLOS ONE, 2017, 12 (12):
  • [16] Zoledronic Acid Reduces Osteonecrosis and Anti-Leukemic Efficacy in Murine Models of Acute Lymphoblastic Leukemia Therapy
    Janke, Laura
    Kim, Jieun
    Jenkins, David
    Payton, Monique A.
    Relling, Mary V.
    Karol, Seth E.
    BLOOD, 2018, 132
  • [17] Direct and indirect anti-leukemic properties of activity-on-target interferons for the treatment of T-cell acute lymphoblastic leukemia
    Goossens, Steven
    Cauwels, Anje
    Pieters, Tim
    De Smedt, Renate
    T'Sas, Sara
    Almeida, Andre
    Daneels, Willem
    Van Vlierberghe, Pieter
    Tavernier, Jan
    HAEMATOLOGICA, 2022, 107 (06) : 1448 - 1453
  • [18] CD22 AS A TARGET FOR ELIMINATION OF THE LEUKEMIC BLASTS IN B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
    Kanderova, V.
    Kuzilkova, D.
    Vaskova, M.
    Kalina, T.
    Hrusak, O.
    Mejstrikova, E.
    HAEMATOLOGICA, 2015, 100 : 342 - 342
  • [19] Sulfonoquinovosyl diacylglyceride selectively targets acute lymphoblastic leukemia cells and exerts potent anti-leukemic effects in vivo
    Chetan Kumar Jain
    Bhola Shankar Pradhan
    Sukdeb Banerjee
    Nirup Bikash Mondal
    Subeer S. Majumder
    Madhumita Bhattacharyya
    Saikat Chakrabarti
    Susanta Roychoudhury
    Hemanta Kumar Majumder
    Scientific Reports, 5
  • [20] CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - AUTOLOGOUS TRANSPLANTATION WITH BONE-MARROW TREATED WITH ANTI-LEUKEMIC ANTIBODIES
    NETZEL, B
    HAAS, RJ
    RODT, H
    KOLB, HJ
    BELOHRADSKY, B
    THIERFELDER, S
    BLUT, 1980, 41 (03): : 237 - 240